栓塞預防設備市場規模、佔有率、成長分析，按類型、按材料、按適應症、按應用、按地區 - 行業預測，2024-2031 年

2022年全球栓塞防護裝置市場規模將為5.5455億美元，從2023年的6.0488億美元成長到2031年的11.4641億美元，並預計在預測期內持續成長（2024年-預計將以複合年成長率成長） 2031 年將成長 8.32%）。

全球栓塞防護設備市場是醫療設備業中快速成長的一個領域，在這種情況下，血栓和血液碎片可能會脫落並穿過血液，導致重要器官阻塞。這些設備在各種侵入性心血管手術中捕捉這些栓子，包括置換術主動脈瓣置換術 (TAVR)、頸動脈支架置入術和經皮冠狀動脈介入治療 (PCI)。該市場的促進因素包括心血管疾病盛行率的增加、老年人口的增加以及微創手術的日益普及。栓塞防護裝置的技術進步，例如新型過濾器設計、生物可吸收過濾器和遠端閉塞系統的開發，正在進一步推動市場成長。此外，醫療保健專業人員對栓塞防護裝置的好處和減少手術併發症的認知不斷提高，導致其採用率不斷提高。市場競爭非常激烈，有幾家主要企業參與開發和行銷這些設備。從地區來看，北美地區所佔佔有率最大，其次是歐洲、亞太地區和其他地區。在技​​術進步、醫療保健支出增加以及新興國家對微創手術需求不斷成長的推動下，全球栓塞防護設備市場預計將繼續呈上升趨勢。

由於對先進醫療技術的需求不斷成長和心血管疾病盛行率上升，預計美國栓塞防護設備市場將在預測期內穩定成長。隨著醫療保健提供者和機構在介入心臟病學等手術過程中繼續優先考慮患者安全，栓塞防護設備的整合變得至關重要。老年人口的成長和微創手術的普及進一步推動了市場的擴張。此外，設備設計和功能的技術進步以及創新產品的監管核准預計將增強市場活力。總之，這些因素顯示美國栓塞防護設備市場前景光明，永續年成長率預計將吸引投資和研究舉措，最終改善心血管手術的患者預後。隨著產業格局的發展，醫療保健相關人員必須繼續關注這些趨勢，以便利用醫療設備業。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 監管環境
• 技術分析
• 專利分析
• 價值鏈分析

栓塞預防設備市場：依類型

• 市場概況
• 遠端過濾裝置
• 遠端阻塞設備
• 近端阻塞設備

栓塞預防設備市場：依材料分類

• 市場概況
• 鎳鈦諾
• 聚氨酯

栓塞預防設備市場：依適應症分類

• 市場概況
• 經皮冠狀動脈介入治療
• 頸動脈疾病
• 大隱靜脈移植疾病
• 經導管主動脈瓣置換術
• 其他適應症

栓塞預防設備市場：依應用分類

• 市場概況
• 心血管疾病
• 神經血管疾病
• 周圍血管疾病

栓塞預防設備市場：依最終使用者分類

• 市場概況
• 醫院
• 門診手術中心

按地區分類的栓塞預防設備市場規模

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Medtronic
• Abbott Laboratories
• Boston Scientific
• Contego Medical
• Silk Road Medical
• Claret Medical
• Allium Medical Solutions
• Edwards Lifesciences
• Healthcare Solutions Holding, LLC
• Innovative Cardiovascular Solutions, LLC
• Transverse Medical, Inc.
• Keystone Heart Ltd.
• InspireMD, Inc.
• AngioDynamics, Inc.
• Emboline, Inc.
• Acandis GmbH & Co. KG
• Veryan Medical Ltd.
• Shanghai MicroPort Medical Co., Ltd.
• MedNova, Inc.

Global Embolic Protection Devices Market size was valued at USD 554.55 million in 2022 and is poised to grow from USD 604.88 million in 2023 to USD 1146.41 million by 2031, growing at a CAGR of 8.32% during the forecast period (2024-2031).

The Global Embolic Protection Devices Market is a rapidly growing sector in the medical device industry that focuses on preventing embolization, a condition where blood clots or debris dislodge and travel through the bloodstream, potentially causing blockages in vital organs. These devices are designed to capture and remove these emboli during various invasive cardiovascular procedures, such as transcatheter aortic valve replacement (TAVR), carotid artery stenting, and percutaneous coronary intervention (PCI). The market is being driven by factors such as the increasing prevalence of cardiovascular diseases, rising geriatric population, and the growing adoption of minimally invasive procedures. Technological advancements in embolic protection devices, such as the development of novel filter designs, bioresorbable filters, and distal occlusion systems, are further propelling market growth. Additionally, the rising awareness among healthcare professionals regarding the benefits of embolic protection devices and the need for reducing procedural complications has led to increased adoption. The market is highly competitive, with several key players involved in the development and distribution of these devices. Geographically, North America currently holds a significant share in the market, followed by Europe, Asia Pacific, and the rest of the world. The Global Embolic Protection Devices Market is expected to continue its upward trajectory in the coming years, driven by technological advancements, increasing healthcare expenditure, and a rising demand for minimally invasive procedures in emerging economies.

The US Embolic Protection Devices Market is expected to experience stable growth over the upcoming forecast period, driven by increasing demand for advanced medical technologies and rising prevalence of cardiovascular diseases. As healthcare providers and facilities continue to prioritize patient safety during procedures such as cardiovascular interventions, the integration of embolic protection devices is becoming essential. The growing geriatric population, coupled with a surge in minimally invasive surgeries, is further fueling market expansion. Additionally, technological advancements in device design and function, as well as regulatory approvals for innovative products, are expected to enhance market dynamics. These factors collectively signal a promising trajectory for the US Embolic Protection Devices Market, indicating a sustainable compound annual growth rate (CAGR) that will attract investment and research initiatives, ultimately improving patient outcomes in cardiovascular procedures. As the landscape evolves, stakeholders in the healthcare sector must remain attuned to these trends to leverage opportunities for growth and innovation in this critical segment of the medical device industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the The Global Embolic Protection Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

The Global Embolic Protection Devices Market Segmental Analysis

Global Embolic Protection Devices Market is segmented by Type, Material, Indication, Application, End User, and Region. Based on Type, the market is segmented into Distal Filter Devices, Distal Occlusion Devices, Proximal Occlusion Devices. Based on Material, the market is segmented into Nitinol, Polyurethane. Based on Indication, the market is segmented into Percutaneous Coronary Intervention, Carotid Artery Diseases, Saphenous Vein Graft Disease, Transcatheter Aortic Valve Replacement, Other Indications. Based on Application, the market is segmented into Cardiovascular Diseases, Neurovascular Diseases, Peripheral Vascular Diseases. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the The Global Embolic Protection Devices Market

The increasing prevalence of cardiovascular diseases is a significant market driver for the Global Embolic Protection Devices Market. As conditions like coronary artery disease, peripheral artery disease, and valvular heart disease become more common globally, the demand for advanced embolic protection devices intensifies. These devices are essential in mitigating complications during invasive cardiovascular interventions, such as stent placements and angioplasty, thereby enhancing overall patient safety and outcomes. Moreover, the growing awareness of the benefits of employing these protective devices in clinical settings further propels their adoption, ultimately fueling market growth as healthcare providers aim to improve procedural success rates and reduce associated risks.

Restraints in the The Global Embolic Protection Devices Market

A significant market restraint for the Global Embolic Protection Devices market is the high cost of these technologies, which can impede their adoption, especially in emerging economies with constrained healthcare budgets. The substantial financial investment required for these devices, coupled with the need for specialized training and expertise for their effective application, creates barriers to entry and limits accessibility in certain regions. Consequently, this financial hurdle may inhibit widespread utilization and growth of the market. To counteract this issue, initiatives aimed at enhancing cost-effectiveness, alongside improved reimbursement frameworks, are essential for promoting broader acceptance and integration of embolic protection devices.

Market Trends of the The Global Embolic Protection Devices Market

The Global Embolic Protection Devices market is witnessing a significant trend driven by the increasing adoption of minimally invasive procedures across various medical specialties. Techniques such as transcatheter aortic valve replacement (TAVR), carotid artery stenting, and percutaneous coronary intervention (PCI) are becoming preferred options due to their benefits, including shorter hospital stays, quicker recovery times, and reduced complication rates when compared to traditional surgical methods. Consequently, there is a heightened demand for advanced embolic protection devices that effectively minimize the risk of emboli during these procedures. This trend is propelling innovation, with manufacturers focusing on developing specialized devices tailored for minimally invasive interventions, aligning with the changing preferences of healthcare providers and patients.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Landscape
• Technology Analysis
• Patent Analysis
• Value Chain Analysis

Embolic Protection Devices Market, By Type

• Market Overview
• Distal Filter Devices
• Distal Occlusion Devices
• Proximal Occlusion Devices

Embolic Protection Devices Market, By Material

• Market Overview
• Nitinol
• Polyurethane

Embolic Protection Devices Market, By Indication

• Market Overview
• Percutaneous Coronary Intervention
• Carotid Artery Diseases
• Saphenous Vein Graft Disease
• Transcather Aortic Valve Replacement
• Other Indications

Embolic Protection Devices Market, By Application

• Market Overview
• Cardiovascular Diseases
• Neurovascular Diseases
• Peripheral Vascular Diseases

Embolic Protection Devices Market, By End User

• Market Overview
• Hospitals
• Ambulatory Surgical Centers

Embolic Protection Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Contego Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Silk Road Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Claret Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allium Medical Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Healthcare Solutions Holding, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Innovative Cardiovascular Solutions, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transverse Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Keystone Heart Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InspireMD, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emboline, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acandis GmbH & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veryan Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai MicroPort Medical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedNova, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments